Overview
Name: Phil Ball, PhD
Current Position: Senior Vice President, Head of Business Development and Operations
Company: Tolerance Bio
Professional Background and Role
Phil Ball is an accomplished biopharmaceutical executive with over 20 years of international experience in business development within the biopharmaceutical industry. At Tolerance Bio, Phil holds the position of Senior Vice President, Head of Business Development and Operations. His role is critical in advancing the company’s strategic goals in the rapidly evolving biotech sector, specifically focusing on immune-mediated diseases.
Educational Background
Phil Ball obtained a Doctor of Philosophy (Ph.D.) in Biochemistry from the University of Liverpool, providing him with a strong foundation in scientific research and development. This complements his robust career in the biopharmaceutical industry, marked by significant leadership roles and achievements.
Company Highlights
Tolerance Bio recently secured $17.2 million in seed financing to pioneer thymus-based therapies for immune-mediated diseases. The company aims to control immune tolerance by restoring and manipulating the thymus function, a strategy that underpins its therapeutic approach in tackling cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergies.
Industry Experience
Phil’s professional trajectory includes numerous leadership roles in prominent biopharmaceutical companies, which precede his current position at Tolerance Bio:
- Innopiphany: Principal, Head of Policy Practice.
- Provention Bio: Vice President, Alliance Management and Business Development.
- Allergan: Multiple executive director positions focusing on U.S. Value Policy and Strategy, and Biologics Policy and Strategy.
- Actavis plc (now Allergan): Director of Biologics Alliance Management and Government Affairs.
Key Achievements
Phil Ball has a proven track record in driving business growth and building strategic alliances within the biopharmaceutical industry. His experience encompasses alliance management, policy strategy development, and technical product management, making him a pivotal figure in Tolerance Bio's leadership team.
Relevance for Sales Background
Phil Ball’s leadership and decision-making capabilities at Tolerance Bio position him as a significant stakeholder influencing the company's business development strategies. His expertise in biologics and policy strategy, coupled with his role in a well-funded startup, indicates potential opportunities for engagement in the areas of strategic partnerships, investment collaborations, and therapeutic development markets.
